Advanced Clear Cell Renal Cell Carcinoma: Putting Advances Into Practice

EP. 1: Evaluation of Risk for Frontline Advanced/Metastatic Clear Cell RCC

July 23rd 2020

EP. 2: Clinical Trials Defining the NCCN Guidelines for Frontline Treatment of mRCC

July 23rd 2020

EP. 3: Applying Clinical Trial Data for Treatment of mRCC

July 23rd 2020

EP. 4: Patient Factor Consideration for Treatment of mRCC

July 23rd 2020

EP. 5: Evaluating Long-Term Follow-Up Data for Treatment of mRCC

July 23rd 2020

EP. 6: CheckMate 9ER: Phase 3 Trial of Frontline Nivolumab + Cabozantinib

July 23rd 2020

EP. 7: Choosing Upfront Therapy for mRCC

July 23rd 2020

EP. 8: Evaluating Safety Profiles of Upfront Regimens for mRCC

July 23rd 2020

EP. 9: Treating Side Effects of Therapy for mRCC with Steroids

July 23rd 2020

EP. 10: Tailored Therapy Approaches for Upfront mRCC Treatment

July 23rd 2020

EP. 11: Choosing Second-Line Therapy in Treatment of mRCC

July 23rd 2020

EP. 12: Clinical Trials Shaping Treatment in Relapsed/Refractory mRCC

July 23rd 2020

EP. 13: Strategies for Switching From Frontline Therapy to Second-Line Therapy in mRCC

July 23rd 2020

EP. 14: Treating Patients With mRCC Beyond Second-Line

July 23rd 2020

EP. 15: Future of Treating mRCC

July 23rd 2020